Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke

Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux

(2015) Hong Xie et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model

(2015) Wen Dong et al.   EXPERIMENTAL NEUROLOGY

White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke

(2015) Jun Suenaga et al.   EXPERIMENTAL NEUROLOGY

Hydrogen Sulfide Inhalation Decreases Early Blood—Brain Barrier Permeability and Brain Edema Induced by Cardiac Arrest and Resuscitation

(2015) Yingjie Geng et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter

(2015) John L. Wallace et al.   NATURE REVIEWS DRUG DISCOVERY

Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA

(2015) Sherif Hafez et al.   Translational Stroke Research

Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke

(2014) Qin Jin et al.   BRAIN BEHAVIOR AND IMMUNITY

Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia

(2014) Yali Wang et al.   JOURNAL OF NEUROCHEMISTRY

Recombinant T Cell Receptor Ligand Treatment Improves Neurological Outcome in the Presence of Tissue Plasminogen Activator in Experimental Ischemic Stroke

(2014) Wenbin Zhu et al.   Translational Stroke Research

Preclinical Evaluation of Recombinant T Cell Receptor Ligand RTL1000 as a Therapeutic Agent in Ischemic Stroke

(2014) Wenbin Zhu et al.   Translational Stroke Research

Thioredoxin 1 Is Essential for Sodium Sulfide–Mediated Cardioprotection in the Setting of Heart Failure

(2013) Chad K. Nicholson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Progesterone Attenuates Hemorrhagic Transformation after Delayed tPA Treatment in an Experimental Model of Stroke in Rats: Involvement of the VEGF–MMP Pathway

(2013) Soonmi Won et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Cystathionine  -Lyase Protects against Renal Ischemia/Reperfusion by Modulating Oxidative Stress

(2013) E. M. Bos et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice

(2012) Lixiang Wang et al.   ANNALS OF NEUROLOGY

VEGFR2 Functions As an H2S-Targeting Receptor Protein Kinase with Its Novel Cys1045–Cys1024 Disulfide Bond Serving As a Specific Molecular Switch for Hydrogen Sulfide Actions in Vascular Endothelial Cells

(2012) Bei-Bei Tao et al.   ANTIOXIDANTS & REDOX SIGNALING

Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury

(2012) J. P. Hunter et al.   BRITISH JOURNAL OF SURGERY

A Novel Hydrogen Sulfide-releasingN-Methyl-d-Aspartate Receptor Antagonist Prevents Ischemic Neuronal Death

(2012) Eizo Marutani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

(2012) Azeb Tadesse Argaw et al.   JOURNAL OF CLINICAL INVESTIGATION

Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke

(2012) L. Mao et al.   NEUROSCIENCE

Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production

(2011) Seok Joon Won et al.   ANNALS OF NEUROLOGY

Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function

(2011) K. Suzuki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hydrogen Sulfide: Neurophysiology and Neuropathology

(2010) Li-Fang Hu et al.   ANTIOXIDANTS & REDOX SIGNALING

Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation

(2010) Moonhee Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators

(2010) Xianfeng Gu et al.   Expert Review of Clinical Pharmacology

Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising

(2010) Matthew Whiteman et al.   Expert Review of Clinical Pharmacology

Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis

(2009) A. Y. Poppe et al.   DIABETES CARE

Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain

(2008) J. An et al.   BLOOD

Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137)

(2008) Ling Li et al.   CIRCULATION

Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke

(2008) Enming J Su et al.   NATURE MEDICINE

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Disruption of the Blood–Brain Barrier After Thrombolytic Therapy Predicts Hemorrhage in Patients With Acute Stroke

(2008) Andreas Kastrup et al.   STROKE